Counterweight Ventures LLC Buys 138 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Counterweight Ventures LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,592 shares of the financial services provider’s stock after acquiring an additional 138 shares during the period. Counterweight Ventures LLC’s holdings in iShares Biotechnology ETF were worth $1,136,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its position in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $18,476,000. DRW Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $5,990,000. Finally, Erste Asset Management GmbH bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $5,678,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.67 on Friday. The firm has a fifty day simple moving average of $136.22 and a two-hundred day simple moving average of $141.41. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.